FibroGen Valuation
| FGEN Stock | USD 1.07 0.07 6.14% |
Today, the firm appears to be fairly valued. FibroGen shows a prevailing Real Value of $1.03 per share. The current price of the firm is $1.07. Our model computes the value of FibroGen from reviewing the firm fundamentals such as Operating Margin of (3.81) %, current valuation of 82.52 M, and Profit Margin of (1.92) % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting FibroGen's valuation include:
Price Book 53.8258 | Enterprise Value 82.5 M | Enterprise Value Ebitda (0.17) | Price Sales 0.869 | Forward PE 61.3497 |
Fairly Valued
Today
Please note that FibroGen's price fluctuation is out of control at this time. Calculation of the real value of FibroGen is based on 3 months time horizon. Increasing FibroGen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for FibroGen is useful when determining the fair value of the FibroGen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of FibroGen. Since FibroGen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of FibroGen Stock. However, FibroGen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.07 | Real 1.03 | Target 2.17 | Hype 1.07 | Naive 1.41 |
The real value of FibroGen Stock, also known as its intrinsic value, is the underlying worth of FibroGen Company, which is reflected in its stock price. It is based on FibroGen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of FibroGen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence FibroGen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of FibroGen helps investors to forecast how FibroGen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of FibroGen more accurately as focusing exclusively on FibroGen's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use FibroGen's intrinsic value based on its ongoing forecasts of FibroGen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against FibroGen's closest peers. When choosing an evaluation method for FibroGen, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
FibroGen Investments |
|
FibroGen Valuation Trend
Knowing FibroGen's actual value is paramount for traders to make sound investment determinations. FibroGen's real value is not only important for the investor to make better decisions but also for a more accurate overall view of FibroGen's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both FibroGen's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
FibroGen Market Cap
FibroGen is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 50.68 Billion. FibroGen adds roughly 105.69 Million in market capitalization claiming only tiny portion of equities under Health Care industry.FibroGen Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining FibroGen's current stock value. Our valuation model uses many indicators to compare FibroGen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FibroGen competition to find correlations between indicators driving FibroGen's intrinsic value. More Info.FibroGen is rated # 4 in price to earning category among related companies. It is one of the top stocks in price to book category among related companies fabricating about 0.55 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for FibroGen is roughly 1.81 . As of the 24th of April 2024, Price To Book Ratio is likely to grow to -0.4. Comparative valuation analysis is a catch-all model that can be used if you cannot value FibroGen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for FibroGen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the FibroGen's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates FibroGen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in FibroGen and how it compares across the competition.
About FibroGen Valuation
The stock valuation mechanism determines the current worth of FibroGen on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of FibroGen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of FibroGen based exclusively on its fundamental and basic technical indicators. By analyzing FibroGen's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of FibroGen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of FibroGen. We calculate exposure to FibroGen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to FibroGen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 128.9 M | 174.1 M | |
| Pretax Profit Margin | (1.94) | (1.84) | |
| Operating Profit Margin | (1.82) | (1.73) | |
| Net Loss | (1.92) | (1.83) | |
| Gross Profit Margin | 0.87 | 1.01 |
8 Steps to conduct FibroGen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates FibroGen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct FibroGen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain FibroGen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine FibroGen's revenue streams: Identify FibroGen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research FibroGen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish FibroGen's growth potential: Evaluate FibroGen's management, business model, and growth potential.
- Determine FibroGen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate FibroGen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
FibroGen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as FibroGen does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 97.3 M | |
| Quarterly Earnings Growth Y O Y | 0.536 | |
| Forward Price Earnings | 61.3497 |
FibroGen Current Valuation Indicators
Valuation refers to the process of determining the present value of FibroGen and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value FibroGen we look at many different elements of the entity such as FibroGen's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. FibroGen's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final FibroGen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as FibroGen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use FibroGen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes FibroGen's worth.When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.